Author:
De Pradip,Dey Nandini,Terakedis Breanne,Bergsagel P. Leif,Li Zhi Hua,Mahadevan Daruka,Garlich Joseph R.,Trudel Suzanne,Makale Milan T.,Durden Donald L.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference44 articles.
1. Bandi P, Blount L, Boone M, Books D, Calle J, Chen A, Cokkinides V, Conner E, Dahl J, Doroshenck M, Doyle C, Gansler T, Glynn T, Heier EJ, Jacobs E, Jorenson D, Kirch R, Klevan W, Laurie D, McGinnis L, Murray T, Noel D, Rodriguez C, Saslow D, Schmidt C, Shafey O, DeSantis C, Smith R, Stefanek M, Summers S, Teschendorf B, Wang S, Weinstock M, Yates J (2007) Cancer facts and figures 2007. American Cancer Society, Atlanta
2. Laubach J, Richardson P, Anderson K (2011) Multiple myeloma. Annu Rev Med 62:249–264
3. Ikeda H, Hideshima T, Fulciniti M, Perrone G, Miura N, Yasui H, Okawa Y, Kiziltepe T, Santo L, Vallet S et al (2010) PI3K/p110{delta} is a novel therapeutic target in multiple myeloma. Blood 116:1460–1468
4. Mitsiades CS, Mitsiades NS, McMullan CJ, Poulaki V, Shringarpure R, Akiyama M, Hideshima T, Chauhan D, Joseph M, Libermann TA et al (2004) Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors. Cancer Cell 5:221–230
5. Ishikawa H, Tsuyama N, Obata M, Kawano M (2006) Mitogenic signals initiated via interleukin-6 receptor complexes in cooperation with other transmembrane molecules in myelomas. J Clin Exp Hematop 46:55–66
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献